Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Similar articles for PubMed (Select 18700814)

1.

The use of nonhuman primate models in HIV vaccine development.

Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu SL, Johnson RP, Lifson J, Montefiori D, Moore J, Robert-Guroff M, Robinson H, Self S, Corey L.

PLoS Med. 2008 Aug 12;5(8):e173. doi: 10.1371/journal.pmed.0050173. No abstract available.

2.

Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.

Staprans SI, Feinberg MB, Shiver JW, Casimiro DR.

Curr Opin HIV AIDS. 2010 Sep;5(5):377-85. doi: 10.1097/COH.0b013e32833d2e19. Review.

PMID:
20978377
3.

Efficacy of AIDS vaccine strategies in nonhuman primates.

Uberla K.

Med Microbiol Immunol. 2005 Aug;194(4):201-6. Epub 2005 Apr 21. Review.

PMID:
15843997
4.

The role of nonhuman primates in the development of an AIDS vaccine.

Nathanson N, Hirsch VM, Mathieson BJ.

AIDS. 1999;13 Suppl A:S113-20. Review.

PMID:
10885770
5.

Developing an HIV vaccine: the role of efficacy studies in nonhuman primates.

Uberla K.

PLoS Med. 2005 Apr;2(4):e119. Epub 2005 Apr 26. No abstract available.

6.

[Immunodeficiency viruses and nonhuman primate models of AIDS].

Klots IN.

Vopr Virusol. 2009 May-Jun;54(3):8-12. Review. Russian.

PMID:
19537090
7.

The impetus for tracking nonhuman primate AIDS vaccine/live virus challenge studies.

Warren JT.

J Med Primatol. 1992 Feb-May;21(2-3):138. No abstract available.

PMID:
1433264
8.

Demand for nonhuman primate resources in the age of biodefense.

Patterson JL, Carrion R Jr.

ILAR J. 2005;46(1):15-22. Review.

9.

HIV/AIDS vaccines: a need for new concepts?

Girard MP, Bansal GP.

Int Rev Immunol. 2008;27(6):447-71. doi: 10.1080/08830180802432160. Review.

PMID:
19065351
10.

Non-human primate models for AIDS vaccines.

Desrosiers RC.

AIDS. 1995;9 Suppl A:S137-41. Review. No abstract available.

PMID:
8819580
11.

Reproductive/developmental toxicity and immunotoxicity assessment in the nonhuman primate model.

Buse E, Habermann G, Osterburg I, Korte R, Weinbauer GF.

Toxicology. 2003 Apr 1;185(3):221-7. Review.

PMID:
12581697
12.

Virology. Moving forward in HIV vaccine development.

Letvin NL.

Science. 2009 Nov 27;326(5957):1196-8. doi: 10.1126/science.1183278. No abstract available.

PMID:
19965456
13.

HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?

Uberla K.

PLoS Pathog. 2008 Aug 29;4(8):e1000114. doi: 10.1371/journal.ppat.1000114. Review. No abstract available.

14.

PLoS takes a step backward.

Pippin JJ.

PLoS Med. 2005 Aug;2(8):e278. Epub 2005 Aug 30. No abstract available.

15.

Moving candidate vaccines into development from research: lessons from HIV.

Sullivan M.

Immunol Cell Biol. 2009 Jul;87(5):366-70. doi: 10.1038/icb.2009.30. Epub 2009 May 12. Review.

PMID:
19434070
16.

The unique value of primate models in translational research. Nonhuman primate models of women's health: introduction and overview.

Shively CA, Clarkson TB.

Am J Primatol. 2009 Sep;71(9):715-21. doi: 10.1002/ajp.20720.

PMID:
19507247
17.

Primate models for HIV vaccines.

Schultz AM, Hu SL.

AIDS. 1993;7 Suppl 1:S161-70. Review. No abstract available.

PMID:
8363780
18.

Vaccine trial begins in South Africa.

[No authors listed]

AIDS Patient Care STDS. 2004 Jan;18(1):59. No abstract available.

PMID:
15085551
19.

Nonhuman primates are relevant models for research in hematology, immunology and virology.

Hérodin F, Thullier P, Garin D, Drouet M.

Eur Cytokine Netw. 2005 Jun;16(2):104-16. Review.

PMID:
15941681
20.

HIV vaccine trial no longer PAVEs the way.

Honey K.

J Clin Invest. 2008 Sep;118(9):2989. doi: 10.1172/JCI36994. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk